(IMAGE)

Research

Caption

The proposed Fe-EGCG@RSL3 system can be easily synthesized through the self-assembly of its basic ingredients. It can be administered either into the bladder or through the bloodstream, since the nanomedicine preferentially targets tumor cells. In addition to directly killing cancer cells through ferroptosis, Fe-EGCG@RSL3 modulates the tumor immune microenvironment in beneficial ways, making immunotherapy more effective.

Credit

Dr. Chengjunyu Zhang from Sun Yat-Sen University, China

Usage Restrictions

Credit must be given to the creator.

License

CC BY

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.